Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Evans Sagwa"'
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
ABSTRACTBackground Effective vaccine management is crucial to maintain vaccine potency. To achieve this, elements, such as temperature management, stock management, infrastructure, cold chain equipment and waste management, need to be properly implem
Externí odkaz:
https://doaj.org/article/5dd9b1f6eadd46229d83fa5e22f72341
Autor:
Nicholus Mutenda, Alexandra Bukowski, Anne-Marie Nitschke, Tuli Nakanyala, Ndapewa Hamunime, Tadesse Mekonen, Francina Tjituka, Greatjoy Mazibuko, Samson Mwinga, David Mabirizi, Evans Sagwa, Rosalia Indongo, Natalie Dean, Michael R Jordan, Steven Y Hong
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0166649 (2016)
The World Health Organization (WHO) early warning indicators (EWIs) of HIV drug resistance (HIVDR) assess factors at individual ART sites that are known to create situations favourable to the emergence of HIVDR.In 2014, the Namibia HIV care and treat
Externí odkaz:
https://doaj.org/article/54e36c142962478fb8fe52849f7a5723
Autor:
Greatjoy Njabulo Mazibuko, Evans Sagwa, Harriet Rachel Kagoya, Dan Kibuule, Timothy Rennie, Tukai Mavere, Reem Ghoneim, David Mabirizi, Ester Naikaku, Qamar Niaz, Jennie Lates
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 7, Iss sup1 (2014)
Externí odkaz:
https://doaj.org/article/538cdba2904945438fdb7795aea6582b
Publikováno v:
Journal of Human Resource and Leadership. 7:1-19
Purpose: The objective of the study was to determine the effect of Strategic Human Resource Management Practices (SHRMPs) on performance of public universities. Methodology: This study was essentially guided by the Resource Based Theory, as exemplifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::256300b87774309efff74c559cb42cab
https://doi.org/10.47604/jhrl.1679
https://doi.org/10.47604/jhrl.1679
Autor:
Kevin Tjoa, Anthony William Brian Iskandar, Evans Sagwa, Melva Louisa, Gilbert Lazarus, Vivian Soetikno, Nesri Padayatchi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 3, p e0248017 (2021)
PLoS ONE, Vol 16, Iss 3, p e0248017 (2021)
Background Adverse events (AEs) during drug-resistant tuberculosis (DR-TB) treatment, especially with human immunodeficiency virus (HIV) co-infection, remains a major threat to poor DR-TB treatment adherence and outcomes. This meta-analysis aims to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f61e2d9e3698e479538d7b8cfba98cd
https://pubmed.ncbi.nlm.nih.gov/33662024
https://pubmed.ncbi.nlm.nih.gov/33662024
Autor:
Bayobuya Phulu, Greatjoy Mazibuko, Lazarus Indongo, Wuletaw Churfo, Samson Mwinga, Evans Sagwa, Tamara Hafner, David Mabirizi
Publikováno v:
Global Health: Science and Practice
Integrating patient and commodity data into one system while maintaining specialized functionality has allowed managers to monitor and mitigate stock-out risks more effectively, as well as provide earlier warning for HIV drug resistance.
The suc
The suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efb753c0e3ab26ca98185de929462bbc
https://doi.org/10.9745/ghsp-d-18-00157
https://doi.org/10.9745/ghsp-d-18-00157
Autor:
Evans Sagwa, Inês Ribeiro, Aukje K. Mantel-Teeuwisse, Hubert G. M. Leufkens, Patrick C. Souverein
Publikováno v:
Pharmacoepidemiology and Drug Safety. 26:1-8
Purpose To evaluate the association between the use of streptomycin, amikacin, kanamycin and capreomycin in tuberculosis (TB) treatment and the pharmacovigilance reporting of ototoxicity (deafness or hearing loss, tinnitus and vertigo). Second, to an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d2ff4e71db7083d7ea78736f5fa3ddb
https://doi.org/10.1002/pds.4125
https://doi.org/10.1002/pds.4125
Autor:
Marita Mann, Greatjoy Mazibuko, Evans Sagwa, Assegid Mengistu, Andy Stergachis, Johannes Gaeseb, Jared M. Baeten, Joseph B. Babigumira, Louis P. Garrison
Publikováno v:
Pharmacoepidemiology and Drug Safety. 25:1052-1060
PURPOSE: Active surveillance pharmacovigilance systems better estimate the burden of adverse events (AEs) and can generate useful information on risk factors of AEs for more effective medicine use especially in conjunction with introduction of new me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26e2795dd5969b46b2c2cb5e4a32cadf
https://doi.org/10.1002/pds.4022
https://doi.org/10.1002/pds.4022
Publikováno v:
International Journal of Clinical Practice
BACKGROUND: Despite Namibia's robust medicine use systems and policies, antibiotic use indicators remain suboptimal. Recent medicine use surveys rank cotrimoxazole, amoxicillin and azithromycin (CAA) among the most used medicines. However, there is r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9c48916fdfa525b93b37923a0eaacb6
https://pubmed.ncbi.nlm.nih.gov/28090718
https://pubmed.ncbi.nlm.nih.gov/28090718
Autor:
Greatjoy Mazibuko, Andy Stergachis, Johannes Gaeseb, Assegid Mengistu, Evans Sagwa, Louis P. Garrison, Joseph B. Babigumira, Marita Mann
Publikováno v:
Drug safety. 39(9)
Active surveillance pharmacovigilance is a systematic approach to medicine safety assessment and health systems strengthening, but has not been widely implemented in low- and middle-income countries. This study aimed to assess the cost effectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdfbfc2e8ccc331f235ec8d7348a323c
https://pubmed.ncbi.nlm.nih.gov/27314405
https://pubmed.ncbi.nlm.nih.gov/27314405